T3 Defense (DFNS) Proxy filing summary

Executive summary

• Supplement details recent share issuances and updates related to the equity line of credit and private placement agreements.

• 15,187,265 shares sold to Esousa Group Holdings, LLC for $3,805,929 under the ELOC Purchase Agreement.

• Additional share issuances between April and June 2026 totaled 17,294,784 shares for $4,545,236 in gross proceeds.

• As of June 15, 2026, 94,832,476 common shares and 200 Series B Convertible Preferred Stock shares are outstanding.

• Forward-looking statements caution about risks and uncertainties regarding future sales under the equity line program.

Voting matters and shareholder proposals

• Proposal One concerns issuance of shares upon exercise of warrants under the Securities Purchase Agreement.

• Proposal Two addresses issuance of shares upon conversion of Series B Convertible Preferred Stock.

• Voting rights are based on shares outstanding as of May 21, 2026, unaffected by subsequent issuances.

Related party transactions

• Esousa Group Holdings, LLC is a significant counterparty in the ELOC Purchase Agreement, with purchases subject to a 9.99% beneficial ownership cap.

• Securities Purchase Agreement with an investor governs private placement and related share issuances.